Liver transplant induction trial of daclizumab to spare calcineurin inhibition

Transplantation Proceedings

Volumn 34, Issue 5, 2002, Pages 1514-1515

  Heffron, T G ^a   Smallwood, G A ^b,d   Pillen, T ^c   Davis, L ^a   Martinez, E ^a   Romero, R ^a   Stieber, A C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; CALCINEURIN; DACLIZUMAB; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; GRAFT REJECTION; HEPATITIS C; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY FUNCTION; LENGTH OF STAY; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME; AGE; ARTICLE; CHILD; COMPARATIVE STUDY; DRUG ANTAGONISM; IMMUNOLOGY; MIDDLE AGED; MORTALITY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION;

ADULT; AGE FACTORS; ANTIBODIES, MONOCLONAL; CALCINEURIN; CHILD; COMPARATIVE STUDY; GRAFT REJECTION; HEPATITIS C; HUMAN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; SURVIVAL RATE; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0035993617     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)02952-4     Document Type: Conference Paper

References (7)